Published on 14 Mar 2024 on Simply Wall St. via Yahoo Finance
Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years...
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of Enzo Biochem, Inc. (NYSE:ENZ) have had an unfortunate run in the last three years. Regrettably, they have had to cope with a 69% drop in the share price over that period. Unfortunately the share price momentum is still quite negative, with prices down 9.6% in thirty days.
It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.
Check out our latest analysis for Enzo Biochem